BofA analyst Tim Anderson raised the firm’s price target on Eli Lilly (LLY) to $1,000 from $997 and keeps a Buy rating on the shares after ...
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
Stock market today: Wall Street drifts as Ford and Qualcomm offset rising fashion and tobacco stocks
Wall Street drifted to a mixed close as drops for Ford Motor and Qualcomm worked against buoyant fashion and cigarette stocks ...
The Dow Jones Industrial Average ( ^DJI) fell 0.3%. The S&P 500 ( ^GSPC) rose more than 0.3%, and the tech-heavy Nasdaq Composite ( ^IXIC) popped 0.5% on the heels of two winning days in a row for the ...
Wall Street is drifting Thursday as gains for fashion brands and cigarette makers help offset drops for Ford Motor and ...
Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.
Comments: Growth in the quarter was driven by Mounjaro, with sales up 60% to $3.5 billion, and Zepbound, with sales of $1.9 billion. New Products revenue, which consists of Ebglyss, Jaypirca, Kisunla, ...
Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...
Wall Street experiences mixed performance as fashion and tobacco stocks surge, while automotive and tech sectors face ...
Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...
Wall Street is drifting Thursday as gains for fashion brands and cigarette makers help offset drops for Ford Motor and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback